Further, clinical analysis on the expression pattern of FoxO1 and SF-1 in patients with obesity and type 2 diabetes could shed more light on the relationship between HPA axis dysregulation and obesity development. Here, FOXO1 is linked to obesity due to melanocortin 4 receptor deficiency.